Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H₁-antihistamines for insomniaSatheesh Babu Ravula, Jinghua Yu, Joe A Tran, et al.Bioorganic & Medicinal Chemistry Letters|March 16, 2010
Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomniaBin-Feng Li, Wilna J Moree, Jinghua Yu, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.Pharmacological Research|November 8, 2025
Kinetic multiplex assay to assess biased signaling of clinical GPCR agonistsJara Bouma, Elisa J M de Koning, Cas van der Horst, et al.Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Novel benzothiophene H1-antihistamines for the treatment of insomniaWilna J Moree, Florence Jovic, Timothy Coon, et al.Journal of Medicinal Chemistry|September 2, 2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsRaymond S Gross, Zhiqiang Guo, Brian Dyck, et al.Journal of Medicinal Chemistry|August 12, 2009
Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Florence Jovic, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaWilna J Moree, Bin-Feng Li, Said Zamani-Kord, et al.Pageof 9